Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in the US. This collaboration marks the starting phase of a ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test.

Every day the Good Good Good team collects the best good news in the world and shares it with our community. Here are the ...

Researchers have found that electric cars might not be as green as they appear since their brakes produce emissions more ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Vitestro's blood drawing (phlebotomy ... hope of one day creating a version that could be kept in the pocket of a lab coat. Meanwhile, in China a larger device – not dissimilar in scale to ...

SiPhox Health expects to field a service that’ll let people conduct blood tests in their homes and see results in about an ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Variety breaks down the best TV performances of the 21st century, from Jeremy Allen White to Emma Stone and Sydney Sweeney.

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.